The mice were intratumorally administered with a single dose of 74 MBq of radioactive nanoparticles. Gradual increase in tumor volume was reported for all the groups except 131I-BSA-MSNPs-anti-VEGFR2-treated group. This evidence concerns the gene KDR and neoplasm.